Andrew S. Greenberg, MD
Scientist I and Director, Obesity and Metabolism Laboratory at the Jean Mayer USDA HNRCA at Tufts University; Assistant Professor, Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy at Tufts University; and Attending Physician at Tufts–New England Medical Center. Research interests include obesity and obesity-related complications, aging, metabolic syndrome, HIV lipodystrophy, cachexia, role of obesity in cancer, and inflammation.
Ira M. Herman, PhD
Professor of Physiology, Tufts University School of Medicine and Director, Integrated Studies Program, Sackler School of Graduate Biomedical Sciences. Dr. Herman is also Professor of Anatomy & Cellular Biology as well as Professor of Ophthalmology, and serves as Co-Director, Tufts Vision Science Center. Dr. Herman’s research has focused on revealing the molecular and cellular mechanisms controlling cell shape and migration during developmental and disease-associated processes, including cell division, angiogenesis and wound healing.
Douglas W. Losordo, MD
Professor of Medicine at Tufts University School of Medicine and Chief of Cardiovascular Research at Caritas
St. Elizabeth's Medical Center. Dr. Losordo has recently completed the first US adult stem cell clinical trial for the treatment of heart disease and is national PI on the largest active study of gene therapy for treatment of angina. His group is developing therapies involving combinations of gene and stem cell therapy for cardiovascular diseases.
Michael E. Mendelsohn, MD, FACC
Executive Director of the Molecular Cardiology Research Institute at Tufts–New England Medical Center, first recipient of the Elisa Kent Mendelsohn Professorship of Molecular Cardiology and Medicine at Tufts University School of Medicine, Vice-Chairman for Scientific Affairs of the Department of Medicine, and Chairman of the Research Executive Committee for Tufts–New England Medical Center. Dr. Mendelsohn has focused on signal transduction pathways regulating vascular tone and function and his laboratory has helped to decipher the mechanisms of action of endogenous vascular protective molecules, including estrogen/estrogen receptors and nitric oxide/cyclic GMP signaling pathways.